CAG
BIO icon

Csenge Advisory Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Csenge Advisory Group’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-427
Closed -$211K – 610
2022
Q2 		$211K Sell
427
-54
-11% -$28.1K 0.02% 530
2022
Q1 		$271K Buy
481
+29
+6% +$17.5K 0.02% 520
2021
Q4 		$297K Buy
452
+1
+0.2% +$748 0.03% 455
2021
Q3 		$335K Sell
451
-1
-0.2% -$749 0.03% 446
2021
Q2 		$297K Sell
452
-5
-1% -$3.04K 0.03% 456
2021
Q1 		$275K Buy
457
+17
+4% +$10.1K 0.03% 407
2020
Q4 		$256K Sell
440
-34
-7% -$19.4K 0.03% 358
2020
Q3 		$253K Buy
474
+31
+7% +$15.7K 0.03% 327
2020
Q2 		$200K Buy
+443
New +$195K 0.03% 357
2018
Q4 		– Sell
-30
Closed -$8K – 345
2018
Q3 		$8K Buy
+30
New +$9.31K ﹤0.01% 539

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return